start great shape
increas forecast price target strong updat
forecast price target follow result deliv
best organ growth decad demonstr
one industri top perform come increas
agil busi model speed innov gs
calendar price-to-earnings seem fulli deserv full momentum
organ growth margin go
strong
manag admit still challeng especi groom
babi work importantli note sign
organis cultur chang also made increas
ep forecast price target
strongest growth decad growth follow
us grew china europ
key driver sequenti acceler price
versu last year categori post posit growth
star perform beauti driven strong growth premium skincar
china health fabric babi
low singl digit weigh babi feminin famili especi
china although perform improv organ growth guidanc
factor potenti competitor respons forecast
gillett impair impair taken manag
state due fx impact revenu sinc acquisit
lower-categori shave incid rather entranc new
competitor manag believ groom remain attract
busi although volum declin full
year categori howev pricing/mix acceler
solid categori growth share gain unlik peer manag
flag moder categori growth us
europ china experienc modest slowdown still
latin america sequenti improv encouragingli ceo refer
construct competitor environ focus innov versu
price-cut-driven share gain share gain build momentum
 gs top countri categori cell hold gain valu
share last year
better margin outlook despit strong top line core
oper margin one-off benefit land
sale hit commod fx headwind offset
strong product gain provid modest tailwind
enabl product benefit fall bottom line
therefor driver mid- high-
single-digit ep growth outlook balanc top
line margin ep benefit share buyback
forecast core ep growth compound-annual-growth-rate
chang made note
hold chang
perform rel
largest manufactur
distributor brand person care
profit loss summari
growth margin
 clearli focus core global mass daily-us person
home care brand believ attain product
execut superior give competit advantag
believ relianc core larg brand restrict gs
abil tap higher-growth market despit troubl spot
groom babi china acknowledg underli
execut improv evid trade ytd
price rise sign organis
cultur chang
highlight advantag advertis digit
categori growth
reach long-term mid- high-single-digit ep growth target
ambiti annual margin improv requir
net invest cost fx inflat reinvest
restrict despit product save
favour
howev despit price-to-earnings gs organ growth momentum
size rel stabil like remain attract
price target base averag peer multipl
dividend subsidiari
firm
chang net debt
average cost debt
risk invest thesi
 highli expos us market consum
environ sluggish retail landscap challeng
buyback sourc upsid risk earn strong
balanc sheet could support higher buyback
recent elect board member investor nelson peltz
call faster chang expect continu
push radic chang intern
pulp price deliveri cost particular risen sharpli
revers cost inflat would creat margin tailwind
figur post best organ growth decad
follow us grew
china europ guidanc
organ growth factor potenti competitor respons
figur key driver sequenti quarterli
acceler price versu last year
categori posit price led fabric
figur categori post posit growth star
perform beauti benefit
strong growth premium skincar china health
fabric partli due henkel woe also due
strong innov pipelin laundri aid groom categori
growth remain challeng volum declin organ
growth improv babi weigh babi feminin famili
especi china although perform improv
 annual organ growth divis
figur despit strong top line margin hit
commod fx headwind offset strong
product gain togeth expect
provid modest tailwind enabl margin improv
product benefit fall bottom line despit
fy
 total product core gross margin core oper margin
figur expect driver mid- high-single-digit ep
growth outlook balanc top line
margin also boost share buyback
forecast core ep growth compound-annual-growth-rate
figur gs calendar price-to-earnings seem fulli deserv
full momentum organ growth margin good
organis chang implement
fulli leverag scale innov digit capabl
 forward price-to-earnings absolut rel global stapl
rel euro stapl
profit loss account
sale
sale gener admin
research develop
advertis promot
properti plant equip
cash equival
depreci amortis
chang work capit
flow oper activ
flow oper activ
flow oper activ
flow oper activ
addit fix asset
proce sale fix asset
acquisition/dispos busi
increase/decreas intang asset
flow invest activ
flow invest activ
flow invest activ
flow invest activ
net proce sale/issu equiti
flow financ activ
flow financ activ
flow financ activ
flow financ activ
pleas note use research report subject condit restrict set forth gener inv
pleas note use research report subject condit restrict set forth gener invest
pleas note use research report subject condit restrict set forth gener inv
pleas note use research report subject condit restrict set forth gener inv
disclosur legal disclaim end document
